278 filings
Page 2 of 14
8-K
oi2bbqgi6
1 Apr 22
Regulation FD Disclosure
4:05pm
8-K
30qlc njduun4wmbnstg
1 Feb 22
Results of Operations and Financial Condition
4:25pm
8-K
9z9 dv9mi3g8a87a
11 Jan 22
Results of Operations and Financial Condition
6:45am
8-K/A
m6788x
4 Nov 21
Completion of Acquisition or Disposition of Assets
4:13pm
8-K
ut21lez7e8
2 Nov 21
Results of Operations and Financial Condition
4:16pm
8-K
t7uqkvr2c4dvh4
1 Oct 21
Other Events
4:53pm
8-K
eira fzkgjmgjet
21 Sep 21
Completion of Acquisition or Disposition of Assets
12:00am
8-K
mwn7ka agmcy
10 Sep 21
Entry into a Material Definitive Agreement
4:06pm
8-K
e1yq7mlw6fo znz363
25 Aug 21
Entry into a Material Definitive Agreement
4:06pm
8-K
jlbuajfj
12 Aug 21
Term Loan Credit Agreement
4:06pm
8-K
pyaqevence5 0g
27 Jul 21
PerkinElmer to Acquire Antibody and Reagent Leader BioLegend
4:33pm
8-K
vq8qekf70c o9oa
26 Jul 21
Results of Operations and Financial Condition
6:35am
8-K
wyrkkap 0j
24 Jun 21
Company anticipates 2Q21 revenue and earnings to be above previously communicated guidance
6:05am
8-K
fvf5qvslqg6xph0crol
4 May 21
Results of Operations and Financial Condition
4:16pm
8-K
g49no6yku3ihsn js
30 Apr 21
Submission of Matters to a Vote of Security Holders
12:00am
8-K
m59bjhf1zyvgssak q34
13 Apr 21
Results of Operations and Financial Condition
4:46pm
8-K
fe31kgu9t19xcn5uqqw
8 Mar 21
Entry into a Material Definitive Agreement
4:11pm
8-K
qnigbo
2 Feb 21
Results of Operations and Financial Condition
4:11pm
8-K
tqfkl1l
11 Jan 21
Regulation FD Disclosure
5:18pm
8-K
6eaanlz lj
11 Jan 21
Results of Operations and Financial Condition
6:05am